ライフサイエンスコーパス: presentation

1 etween gene transcript levels and HLA ligand presentation.

2 characterized by a highly variable clinical presentation.

3 virus was detected in the CSF at the time of presentation.

4 n activity during the unimodal A (but not V) presentation.

5 at the time of the patient's initial disease presentation.

6 ns to target antigens with ultra-low surface presentation.

7 circulating biomarkers measured at hospital presentation.

8 tion, enriched for IFN signaling and antigen presentation.

9 nting with acute cSAH and 97 without cSAH at presentation.

10 e they usually require amphetamine for their presentation.

11 gens in the context of CD1d-mediated antigen presentation.

12 rum of this gene and the associated clinical presentation.

13 (SNAP and DETA-NONOate) inhibited DC antigen presentation.

14 yndrome, which shows disparities in clinical presentation.

15 c and nonhemorrhagic groups based on initial presentation.

16 possible' bvFTD diagnostic criteria at first presentation.

17 nd standard-sensitivity cTn were measured at presentation.

18 ng various organs and has a diverse clinical presentation.

19 in females compared to males during stimulus presentation.

20 igrating have been activated towards antigen presentation.

21 , if modified in people, might alter disease presentation.

22 impairment in fear memory extinction to tone presentation.

23 CC patients were categorized by MC status at presentation.

24 ents with a m.3243 A > G negative MELAS-like presentation.

25 ticulum-phagosome traffic required for cross-presentation.

26 was already present in 62 patients at first presentation.

27 disease, but substantially modifies disease presentation.

28 eurosurgical patients during visual stimulus presentation.

29 lly learning the rules of endogenous antigen presentation.

30 nterferons and hence enhances tumour antigen presentation.

31 ure that subjects have control over stimulus presentation.

32 lecule H2-O, a negative regulator of antigen presentation.

33 anage repeat patients or more complicated TB presentations.

34 cobacteria and have autoinflammatory disease presentations.

35 to minimally symptomatic or non-symptomatic presentations.

36 A interference (RNAi) in both early and late presentations.

37 fluence of contrast was strongest with brief presentations.

38 characteristic clinical and histopathologic presentations.

39 Bleeding was rare at presentation (5%) and manifested subsequently in fewer t

40 CASE PRESENTATION: A 22-year-old African gentleman presented

41 CASE PRESENTATION: A 31-year-old woman was referred with repe

42 CASE PRESENTATION: A 38-year-old previously healthy woman pre

43 CASE PRESENTATION: A 50 year male presented with acute onset

44 CASE PRESENTATION: A 52 year-old diabetic woman collapsed at

45 CASE PRESENTATION: A 55 year old gentleman was diagnosed with

46 On univariate analysis, presentation age, foveal retinoblastoma (at initial exam

47 However, stimulus presentation alone does not affect primary visual cortex

48 ing expression of genes required for antigen presentation along with those for T cell tolerance.

49 CI 1.11-1.38) in children with diarrhoea at presentation and 1.76 (1.47-2.11) in children without di

50 sepsis and septic shock patients at initial presentation and 2) determine the association between ti

51 a combination of both time-dependent antigen presentation and a novel mechanism through which IL-12 a

52 A is highly variable and depends on clinical presentation and anatomic location.

53 impaired fetal growth, preterm birth, breech presentation and cesarean section were associated with a

54 Substantial overlap exists in the clinical presentation and comorbidities among patients with Middl

55 ecretory granules for antigen processing and presentation and creating a feed-forward loop of T-cell-

56 Cross-presentation and crosspriming depend not only on TLR9, b

57 ignificantly enhanced antigen-specific cross-presentation and cytotoxic T lymphocyte (CTL) activity.

58 rial spike count variability during stimulus presentation and decision formation.

59 ade by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a

60 ed to the individual patient on the basis of presentation and hemodynamic conditions may be beneficia

61 enging due to the highly variable phenotypic presentation and limited correlation has been identified

62 To describe the clinical presentation and outcomes of patients with ICU-necessita

63 lement activation, can modulate both antigen presentation and T cell priming, ultimately leading to a

64 uppressed CD23-mediated facilitated allergen presentation and Th2 cytokine production.

65 We show that MCs adapt to continuous odor presentation and that mixture responses are different wh

66 osition, which has an impact on the clinical presentation and the underlying disease that triggers cr

67 the consecutive NAION event based on initial presentation and to compare mean visual loss of firstly

68 ENIGMA-Viewer supports presentations and communications of brain research resul

69 44, 69] vs 70 [52, 78]; p < 0.001), clinical presentations and comorbidities overlapped substantially

70 r integrating themes emerged across workshop presentations and discussion and centered on 1) physiolo

71 The meeting included formative didactic presentations and facilitated breakout discussions using

72 Primary outcomes were repeat clinic presentations and growth over 24 wk.

73 P-SCAD patients had more acute presentations and high-risk features than women with NP-

74 The workshop presentations and panel discussions focused on current u

75 and not just reserved for those with severe presentations and poor outcomes.

76 ctome visualizations for users' own research presentations and publications.

77 R) Country Operational Plans, and conference presentations and/or abstracts for the latest available

78 edian of 4.4 years, many from first clinical presentation, and 106 scans of 80 healthy paediatric par

79 iation dose, bilateral ocular involvement at presentation, and advanced stage were significantly corr

80 egradation, cholesterol homeostasis, antigen presentation, and cell invasion.

81 Demographics, clinical history, presentation, and in-hospital treatments were compared b

82 the molecular basis that governs the antigen presentation, and the interactions between antigens and

83 Hazard rates of AT across lifetime, age at presentation, and the time lapse between surgery and the

84 s suggesting that other mechanism of antigen presentation are driving the robust T cell response obse

85 utive caspase-1 activation, their phenotypic presentations are different, implying that these mutatio

86 across a spectrum of coronary artery disease presentations are warranted.

87 a cardiac troponin I threshold of 5 ng/L at presentation as a risk stratification tool in patients w

88 Still rarer is its presentation as sclerosing cholangitis.

89 revealed a hierarchical pattern of spot sign presentations, as follows: A > B > C > D > no spot sign

90 third family had a similar but earlier-onset presentation associated with brain hypomyelination.

91 To characterize the incidence, types, presentations, associated factors, and outcomes of neona

92 ho underwent appendectomy within 24 hours of presentation at 23 children's hospitals from January 1,

93 from each participant, including phenotypic presentation at birth and disease course.

94 17/221 promoted beta1 integrin recycling and presentation back onto the surface of macrophages, in pa

95 ilding on a largely morphology- and clinical presentation-based strategy.

96 findings in the context of patient clinical presentations because accurate interpretation of pathoge

97 A third sibling also died of a similar presentation, but DNA was unavailable to confirm the mut

98 e that M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promote

99 ed with a marked inhibition in antigen cross-presentation by Igfbp7(-/-) dendritic cells.

100 Peptide antigen presentation by major histocompatibility complex (MHC) c

101 first described as processors of antigen for presentation by major histocompatibility complex molecul

102 1, 2013, and March 31, 2014, 1647 self-harm presentations by 1153 patients were recorded.

103 change in voice, and dry skin, but clinical presentation can differ with age and sex, among other fa

104 The ability to recognize these variable presentations can be important for the diagnosis of TSC.

105 Recognition of these variable presentations can be important for TSC diagnosis.

106 , neutrophils consistently displayed antigen presentation capability.

107 FN-gamma-responsive genes related to antigen presentation, chemokine expression, cytotoxic activity,

108 pathways including those involved in antigen presentation, chemotaxis, innate and adaptive immunity a

109 ility of S. aureus, heterogeneity of disease presentation, clinical course, and outcome between indiv

110 e shorter delays from symptom development to presentation compared with women who had never undergone

111 h adenovirus, a model for intrahepatic cross-presentation, confirms hepatocytes directly contribute t

112 our data reveal a mechanism by which antigen presentation controls the innate effector function of Th

113 re the first record of 1 of 4 cardiovascular presentations (coronary heart disease [CHD], cerebrovasc

114 were divided into 2 groups based on date of presentation: decade 1 (1995-2005) and decade 2 (2006-20

115 retinitis involving >/=25% of the retina at presentation detached at nearly 12 times the rate, as co

116 To expand understanding of presentation, diagnosis, and outcomes of hemorrhagic occ

117 ch as pathophysiology, patient demographics, presentation, diagnosis, treatment, and outcomes, were e

118 eal fetus in fetu and discusses its clinical presentation, differential diagnosis and embryologic ori

119 nown, and it is unclear whether the clinical presentation differs between patients positive for PLA2R

120 ved TAMs played more potent roles in antigen presentation, embryonically derived TAMs exhibited a pro

121 The material chemistry, presentation, environmental conditions and testing metho

122 nalyze Sec61's contribution to antigen cross-presentation, ERAD, and transport of internalized antige

123 This review will give an overview of the presentation, evaluation, and treatment of immunocompete

124 DCs from these mice show impaired cross-presentation ex vivo and defective cross-priming of CD8(

125 he importance of the temporal pattern of Dpp presentation for morphogenesis of the wing.

126 pporting an impaired endocytic lipid antigen presentation for T cell activation upon benzo[a]pyrene e

127 hospital resource use and care costs for all presentations for self-harm to the John Radcliffe Hospit

128 Three working groups addressed the presentation format, the reference data supporting inter

129 ial Results, CardioSource, and abstracts and presentations from major cardiovascular meetings up to A

130 bMed and Embase and conference abstracts and presentations from the Conference on Retroviruses and Op

131 tem in ALS may translate into the split hand presentation, gait disturbance, split leg syndrome and b

132 y induce T-cell proliferation and an antigen presentation gene expression signature.

133 was associated with upregulation of antigen presentation genes, which correlated (r=0.78) with T-cel

134 In contrast, conditions of sequential presentation have been assumed to be free from competiti

135 Myocarditis was diagnosed based on clinical presentation, high-sensitivity troponin T, and cardiac m

136 Clinical presentations, histopathologic features, laboratory exam

137 Troponin concentrations <5 ng/L at presentation identified 17% of patients with renal impai

138 ad 20/40 (or equivalent) or better vision at presentation in at least 1 eye.

139 d we aimed at studying IgE-dependent antigen presentation in both cell types.

140 dy demonstrates a mechanism regulating cross-presentation in cancer and suggests potential therapeuti

141 We conclude that Sec22b-dependent cross-presentation in DCs is required to initiate CD8(+) T cel

142 using death, place of death, time from index presentation in last year of life to death, whether enro

143 reactivated with either i.v. or i.p. cocaine presentation in the absence of any cue.

144 Clinical presentation in three of the four patients is remarkably

145 nse by efficiently stimulating antigen cross-presentation in vivo and in vitro assessed by BMDC OT-I

146 ygdala and cortical areas to repeated threat presentations in a prospective study of PTSD.

147 till learning more about the myriad clinical presentations in these severely affected children, it is

148 n essential component of MHC class I antigen presentation, in 29.4% of patients with progressing dise

149 HspQ via a C-terminal degron, whose precise presentation, in synergy with multipartite contacts with

150 CASE PRESENTATION: In this vignette, we describe a 73 year-ol

151 owed that expression of mediators of antigen presentation, including MHC class I and beta2 microglobu

152 n of genes related to antigen processing and presentation, including the gene encoding the major hist

153 bilities with three main phenotypic clinical presentations, including logopenic, non-fluent/agrammati

154 CI: 1.07, 1.92; p = 0.016), with respiratory presentations increasing by 52% with fortified SQ-LNS (a

155 ve been associated with overlapping clinical presentations, indicating shared and distinct functions

156 ng that Sec61 blockade affects antigen cross-presentation indirectly.

157 Cue presentation induces retrieval of the drug-cue memory, w

158 ary syndrome and non-acute coronary syndrome presentations (interaction P=0.15).

159 CASE PRESENTATION: Intraoperative spectral domain optical coh

160 most significantly associated with clinical presentation: intrarenal polyomavirus load levels and Ba

161 -corrected visual acuity (BCVA) was 20/30 at presentation (IQR, 0.00-0.50) and remained at 20/30 thro

162 Cross-presentation is a critical function of dendritic cells (

163 The mean time to presentation is approximately 10 years after implant pla

164 More rarely, the clinical presentation is characterised by non-length-dependent, f

165 The visual presentation is intuitive and browsing is fluid, providi

166 Disease presentation is variable, often coinciding with loss of

167 a consortium aiming to describe the clinical presentation, management, and outcomes of patients with

168 an action, and yoked extinction, with shock presentation matched to the active condition, but withou

169 with the same disease and a similar clinical presentation may have very different outcomes and need v

170 last examination, 64.41 +/- 6.76 months from presentation, mean final VA was 20/283 (logMAR equivalen

171 We postulated that lipid antigen presentation mediated by cluster of differentiation 1 (C

172 This increased E75 cross-presentation, mediated by trastuzumab treatment, enabled

173 cytokine module that, along with the antigen presentation module, promoted the generation of effector

174 Endocarditis was the most common presentation (n = 11).

175 Within 2 years of presentation, normalization of function occurs in 20% of

176 linical, and echocardiographic data at first presentation of 1992 patients with BAV (71.5% men) were

177 The clinical presentation of a C. sativa allergy varies from mild to

178 clinical phenotype ranges from the classical presentation of a congenital myasthenic syndrome in one

179 ose-derived stem cells (hASCs), allowing the presentation of a continuous range of stiffnesses in a s

180 ensity EEG, we show that, already before the presentation of a critical word, context-induced semanti

181 sker response amplitude is also modulated by presentation of a movie recreating the mouse's visual ex

182 Accordingly, poor presentation of a mutation across patients was correlate

183 Here we demonstrate that presentation of a novel visual stimulus (a single orient

184 a that shows increased c-Fos expression upon presentation of a sour tastant (30 mM citric acid).

185 These findings are relevant to the clinical presentation of acetaminophen-hepatotoxicity and may inf

186 ow Ragulator functions as a platform for the presentation of active Rags for mTORC1 recruitment, and

187 nventional retinotopic mapping with episodic presentation of adjacent stimuli, a continuous, periodic

188 a cancer diagnosis, understand the clinical presentation of adult patients with cancer in the ED, an

189 rms hepatocytes directly contribute to cross-presentation of Ags and priming the pool of naive CD8(+)

190 an trace conditioning procedure in which the presentation of an auditory cue and food were separated

191 al autophagy, key processes that control the presentation of antigens by dendritic cells (DCs) to nai

192 y, consistent with their defect in the cross-presentation of apoptotic cells, DC-specific Vps34-defic

193 aper, we aimed to report an atypical imaging presentation of CPAM type II in the second trimester, ex

194 two complementary theories that explain the presentation of disease symptoms on the basis of changes

195 a combination of factors, including earlier presentation of disease, fewer eyes being observed witho

196 tructive to productive and facilitates cross-presentation of disease-relevant epitopes to CD8(+) T ce

197 ven when the non-rest condition includes the presentation of emotional provoking stimuli, particularl

198 od, patient age and multi-morbidity at first presentation of heart failure increased (mean age 76.5 y

199 Our model predicts surface presentation of HIV peptides over time, demonstrates the

200 e and evolution of clinical and pathological presentation of HIV-associated neurocognitive disorders

201 transcription factor Foxp3 in T cells, trans-presentation of IL-6 by DC-bound IL-6Ralpha (called 'IL-

202 present study we investigated Ag uptake and presentation of in vivo-formed Ag-Ab complexes by i.v. i

203 in clinical practice as well as the diverse presentation of intestinal melanoma metastases and the d

204 Presentation of magnetic resonance imaging (MRI) finding

205 by trypanosomes and are associated with the presentation of neurological disturbances independently

206 nfirmation of previously described genes and presentation of novel candidates and provide an overview

207 to the ASCO membership after publication or presentation of potential practice-changing data.

208 luding breast cancer, which results in cross-presentation of PR1, an NE-derived HLA-A2-restricted pep

209 sion injury also promoted DC-dependent cross-presentation of renal antigens to CD8 T cells in the dra

210 racranial recordings and visual word-by-word presentation of sentences and word lists to investigate

211 utations of pattern separation to subsequent presentation of similar stimuli.SIGNIFICANCE STATEMENT T

212 The multivalent presentation of specific carbohydrates by using 3D fulle

213 s other than breast cancer prior to clinical presentation of that cancer, for ductal carcinoma in sit

214 paration of the prediction interval from the presentation of the final sentence item.

215 emical inhibition of Usp14 diminished direct presentation of the model antigenic peptide, and the eff

216 tem cell cultures do not control the spatial presentation of the protein.

217 al cells (TECs) through their expression and presentation of tissue-specific Ags to developing thymoc

218 nt biological or neural damage, (b) to avoid presentation of uncomfortably loud sounds, and (c) to en

219 e and prolonged duration, implying prolonged presentation of viral antigens.

220 ds, beginning prior to water ingestion, upon presentation of water-predicting cues.

221 ly healthy obese individuals and 4 different presentations of incident cardiovascular disease in a co

222 ably diagnose the whole spectrum of clinical presentations of PJI.

223 New research criteria that recognise early presentations of PSP and operationalise diagnosis of the

224 There are 2 predominate phenotypic presentations of the disease: transthyretin familial amy

225 t different choices when faced with repeated presentations of the same evidence.

226 eremia), in patients at the time of clinical presentation on IL-10 production and its association wit

227 drates and the diverse array of carbohydrate presentations on the cell surface.

228 Further understanding of risk factors, presentation, optimal management of, and screening for u

229 the CS and during the ISI, but not during US presentations or in the ITI) after infusion in mPFC, whe

230 genes that are more associated with clinical presentations or other genotypic markers.

231 F]FEPPA VT and duration of illness, clinical presentation, or neuropsychological measures after adjus

232 tic biomolecules often result in short-lived presentations, or require genetic manipulation to facili

233 onsider duration range, number of trials and presentation order as crucial factors modulating perform

234 Our results constitute the first report of presentation order effects in the Episodic Temporal Gene

235 results are scale-free and unaffected by the presentation order of the stimuli.

236 determine the association of gender with the presentation, outcome, and host response in critically i

237 present across the entire period of patient presentation, particularly in those experiencing a secon

238 is the single most selective step in the Ag-presentation pathway.

239 ate that functional Usp14 enhances direct Ag presentation, preferentially of DRiP-derived peptides, s

240 l age at birth, birthweight, stage of ROP at presentation, prior treatment (laser or cryotherapy), su

241 Clinical presentations range from self-limited disease to severe

242 Rats learned to increase the presentation rate of the selected theta to beta-gamma (t

243 ants' performance improved with asynchronous presentation relative to synchronous - temporal ventrilo

244 and challenge the assumption that sequential presentation removes competition.

245 The clinical presentation runs a spectrum, ranging from headache and

246 eloped and applied a residue-centric patient presentation score to 9,176 cancer patients across 1,018

247 of cortical activity before and during tone presentation shows that these changes in evoked and spon

248 Additionally, presentation specifically from DRiP Ags was diminished b

249 The "For Presentation" standard-dose mammograms and synthetic ima

250 contribution of factors critical to epitope presentation, such as protein cleavage and gene expressi

251 atter progressively increased after clinical presentation, suggesting not only a failure of age-expec

252 Genetic cases were significantly younger at presentation than Clinical cases (40.6+/-12.5 vs. 47.5+/

253 n discovered to have impaired vision, with a presentation that resembles syndromes of elevated intrac

254 The more arterial the pattern of spot sign presentation, the greater the frequency of substantial h

255 reward-based effects required long stimulus presentation, the influence of contrast was strongest wi

256 At presentation, the mean tumor thickness was 3.39 mm (rang

257 With simultaneous presentation, the measure of WM precision was significan

258 At initial presentation, the median CTG expansion size was 530 (int

259 was the odds of discharge within 6 hours of presentation There were 11 529 participants in the preim

260 w report that ImmunoCloak interrupts antigen presentation thereby preventing early T cell activation

261 However, in those with severe presentations, this proportional recovery applies in onl

262 and 55 (38.2%) visually impaired patients at presentation to 2 (1.4%) and 5 (3.5%) patients respectiv

263 Endogenous myelin peptide presentation to CD4(+) T cells following phagocytosis of

264 Primary outcomes were time from presentation to documentation of symptom resolution and

265 ake a pragmatic comparison of the risk of re-presentation to hospital with vivax malaria in patients

266 nfirmed EVD had similar Ebola viral loads on presentation to nonpregnant women, as measured by initia

267 erbation of symptoms within 2 years of first presentation to psychiatric services.

268 ore, this system allows for LC-restricted Ag presentation to T cells.

269 nation of three standard criteria including: presentation to the emergency department for medical car

270 nal end of this epitope dramatically improve presentation to these T cells.

271 rent knowledge of the epidemiology, clinical presentation, treatment, and pathogenesis of these tumor

272 urther on to humans, and the severe clinical presentation typical in these latter incidental hosts.

273 of T cells stimulated by IL-2 and by antigen presentation using a Theileria-transformed cell line and

274 Clinical presentation varied with age but not by serotypes in the

275 Mean age at presentation was 41.8 (range 3.3-81.6) years.

276 Delay of appendectomy within 24 hours of presentation was not associated with increased risk of c

277 sol, suggesting that the inhibition of cross-presentation was not related to either of these traffick

278 A trend toward an increased bleeding rate at presentation was observed in HHT (p = 0.069) and an incr

279 nd the effect was especially pronounced when presentation was restricted to the defective ribosomal p

280 Through this presentation we show the remarkable similarities and dif

281 CASE PRESENTATION: We present a 51-years-old woman with relev

282 CASE PRESENTATIONS: We report on two siblings with KS.

283 matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of p

284 with cardiogenic shock or cardiac arrest on presentation were excluded.

285 he risk stratification threshold (5 ng/L) at presentation were reported for a primary outcome of inde

286 Numbers of ambulatory and ED diplopia presentations were estimated using weighted sample data.

287 1150 (70%) presentations were for self-poisoning alone, 367 (22%) f

288 esulted in both higher and prolonged antigen presentation when compared to disulfide-linked peptide.

289 The mean time from surgical procedure to presentation with endophthalmitis was 6.8 months (range:

290 than 23% as a measure of hydration status at presentation with HUS was associated with the developmen

291 The risk of re-presentation with P. vivax malaria was higher in childre

292 This delay between the presentation with symptoms and the ability to make an in

293 Presentation with ulcer or gangrene, age >/=65 years, fe

294 The risk of re-presentation with vivax malaria within 1 year was 33.8%

295 CABG over PCI no longer varied by acuity of presentation, with a hazard ratio for MACCE in ACS patie

296 rganisms can be optimized by manipulating Ag presentation, with implications for vaccine design.

297 harbor high-risk histopathologic features at presentation, with the absence of vitreous seeds being a

298 sing of Gag can lead to a 50% probability of presentation within 3 hours post-infection, as observed

299 EFE, as patients are typically ambulatory on presentation without systemic signs of infection.

300 We hypothesized that the rapid presentation would reduce salience (the sudden appearanc